Detalhe da pesquisa
1.
Impact of Low Skeletal Muscle Mass on the Prognosis of Patients with Head and Neck Cancer Treated Nonsurgically.
ORL J Otorhinolaryngol Relat Spec
; 85(1): 36-43, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36423591
2.
Factors Affecting Nivolumab Therapy Outcome in Patients with Head and Neck Cancer: A Single-Center Analysis.
Oncology
; 100(4): 203-211, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35042219
3.
Post-treatment Neutrophil/Lymphocyte Ratio Is a Prognostic Factor in Head and Neck Cancers Treated With Nivolumab.
Cancer Diagn Progn
; 4(2): 182-188, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38434918
4.
A Spatial Transcriptome Reveals Changes in Tumor and Tumor Microenvironment in Oral Cancer with Acquired Resistance to Immunotherapy.
Biomolecules
; 13(12)2023 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38136558
5.
Prognostic significance of pre- and post-treatment hematological biomarkers in patients with head and neck cancer treated with chemoradiotherapy.
Sci Rep
; 13(1): 3869, 2023 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36890182
6.
Perioperative management of a patient with a giant thyroglossal duct cyst: a case report.
J Surg Case Rep
; 2022(6): rjac309, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35783240
7.
Frequency and clinical features of hearing loss caused by STRC deletions.
Sci Rep
; 9(1): 4408, 2019 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30867468
8.
Diagnostic pitfalls for GJB2-related hearing loss: A novel deletion detected by Array-CGH analysis in a Japanese patient with congenital profound hearing loss.
Clin Case Rep
; 6(11): 2111-2116, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30455902
9.
Etiology of single-sided deafness and asymmetrical hearing loss.
Acta Otolaryngol
; 137(sup565): S2-S7, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28366032